Macular Oedema in Idiopathic Macular Telangiectasia Type 1 Responsive to Aflibercept but Not Bevacizumab
We report a patient with macular oedema due to type 1 macular telangiectasia responding to intravitreal aflibercept injection. A 51-year-old man was diagnosed with type 1 idiopathic macular telangiectasia (IMT) in the right eye. The macular oedema was refractory to initial treatment with intravitrea...
Saved in:
Main Authors: | O’Sam Shibeeb, Anagha Vaze, Mark Gillies, Timothy Gray |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | Case Reports in Ophthalmological Medicine |
Online Access: | http://dx.doi.org/10.1155/2014/219792 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Macular Oedema Related to Idiopathic Macular Telangiectasia Type 1 Treated with Dexamethasone Intravitreal Implant (Ozurdex)
by: Mohamed Loutfi, et al.
Published: (2014-01-01) -
Unusual Presentation of Type 1 Idiopathic Macular Telangiectasia
by: Zaïnab Bentaleb Machkour, et al.
Published: (2017-01-01) -
Intravitreal Aflibercept Outcomes in Patients with Persistent Macular Exudate Previously Treated with Bevacizumab and/or Ranibizumab for Neovascular Age-Related Macular Degeneration
by: David R. Griffin, et al.
Published: (2014-01-01) -
Pars Plana Vitrectomy Combined with Focal Endolaser Photocoagulation for Idiopathic Macular Telangiectasia
by: Gaku Terauchi, et al.
Published: (2014-01-01) -
Surgical Outcomes in Macular Telangiectasia Type 2-Related Macular Holes: A Report on Four Patients
by: Kinza T. Ahmad, et al.
Published: (2020-01-01)